Literature DB >> 11429237

Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration.

E A Barnes1, B R Murray, D M Robinson, L J Underwood, J Hanson, W H Roa.   

Abstract

PURPOSE: To examine the dosimetric benefit of self-gated radiotherapy at deep-inspiration breath hold (DIBH) in the treatment of patients with non-small-cell lung cancer (NSCLC). The relative contributions of tumor immobilization at breath hold (BH) and increased lung volume at deep inspiration (DI) in sparing high-dose lung irradiation (> or = 20 Gy) were examined. METHODS AND MATERIALS: Ten consecutive patients undergoing radiotherapy for Stage I-IIIB NSCLC who met the screening criteria were entered on this study. Patients were instructed to BH at DI without the use of external monitors or breath-holding devices (self-gating). Computed tomography (CT) scans of the thorax were performed during free breathing (FB) and DIBH. Fluoroscopy screened for reproducible tumor position throughout DIBH, and determined the maximum superior-inferior (SI) tumor motion during both FB and DIBH. Margins used to define the planning target volume (PTV) from the clinical target volume included 1 cm for setup error and organ motion, plus an additional SI margin for tumor motion, as determined from fluoroscopy. Three conformal treatment plans were then generated for each patient, one from the FB scan with FB PTV margins, a second from the DIBH scan with FB PTV margins, and a third from the DIBH scan with DIBH PTV margins. The percent of total lung volume receiving > or = 20 Gy (using a prescription dose of 70.9 Gy to isocenter) was determined for each plan.
RESULTS: Self-gating at DIBH was possible for 8 of the 10 patients; 2 patients were excluded, because they were not able to perform a reproducible DIBH. For these 8 patients, the median BH time was 23 (range, 19-52) s. The mean percent of total lung volume receiving > or = 20 Gy under FB conditions (FB scan with FB PTV margins) was 12.8%. With increased lung volume alone (DIBH scan with FB PTV margins), this was reduced to 11.0%, tending toward a significant decrease in lung irradiation over FB (p = 0.086). With both increased lung volume and tumor immobilization (DIBH scan with DIBH PTV margins), the mean percent lung volume receiving > or = 20 Gy was further reduced to 8.8%, a significant decrease in lung irradiation compared to FB (p = 0.011). Furthermore, at DIBH, the additional benefit provided by tumor immobilization (i.e., using DIBH instead of FB PTV margins) was also significant (p = 0.006). The relative contributions of tumor immobilization and increased lung volume toward reducing the percent total lung volume receiving > or = 20 Gy were patient specific; however, all 8 of the patients analyzed showed a dosimetric benefit with this DIBH technique.
CONCLUSION: Compared to FB conditions, at DIBH the mean reduction in percent lung volume receiving > or = 20 Gy was 14.3% with the increase in lung volume alone, 22.1% with tumor immobilization alone, and 32.5% with the combined effect. The dosimetric benefit seen at DIBH was patient specific, and due to both the increased lung volume seen at DI and the PTV margin reduction seen with tumor immobilization.

Entities:  

Mesh:

Year:  2001        PMID: 11429237     DOI: 10.1016/s0360-3016(01)01592-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

Review 1.  Lung cancer 5: state of the art radiotherapy for lung cancer.

Authors:  A Price
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  A novel technique for markerless, self-sorted 4D-CBCT: feasibility study.

Authors:  Irina Vergalasova; Jing Cai; Fang-Fang Yin
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

Review 3.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

Review 4.  MRI in medical practice and its future use in radiation oncology. Resume of XXV GOCO Congress (Montpellier) 2017.

Authors:  Xavier Druet; Estrella Acosta Sanchez; Ken Soleakhena; Anne Laprie; Jordi Sáez; Stéphanie Nougaret; Olivier Riou; Elodie Rigal; Laura Kibranian; Miguel Palacios; Ismael Membrive
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-05

Review 5.  Stereotactic body radiotherapy: current strategies and future development.

Authors:  Maverick W K Tsang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.

Authors:  Anna Simeonova-Chergou; Anika Jahnke; Kerstin Siebenlist; Florian Stieler; Sabine Mai; Judit Boda-Heggemann; Frederik Wenz; Frank Lohr; Lennart Jahnke
Journal:  Strahlenther Onkol       Date:  2016-01-15       Impact factor: 3.621

Review 7.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

8.  On the accuracy of a moving average algorithm for target tracking during radiation therapy treatment delivery.

Authors:  Rohini George; Yelin Suh; Martin Murphy; Jeffrey Williamson; Elizabeth Weiss; Paul Keall
Journal:  Med Phys       Date:  2008-06       Impact factor: 4.071

9.  Markerless tumor tracking using short kilovoltage imaging arcs for lung image-guided radiotherapy.

Authors:  Chun-Chien Shieh; Paul J Keall; Zdenka Kuncic; Chen-Yu Huang; Ilana Feain
Journal:  Phys Med Biol       Date:  2015-11-19       Impact factor: 3.609

10.  Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison.

Authors:  Jessica Prunaretty; Pierre Boisselier; Norbert Aillères; Olivier Riou; Sebastien Simeon; Ludovic Bedos; David Azria; Pascal Fenoglietto
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.